Y. L. Wang

发表

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms

Andrew Collins, Andrew Chase, Nicholas C P Cross, 2009, Nature Genetics.

Laboratory Practice Guidelines for Detecting and Reporting JAK 2 and MPL Mutations in Myeloproliferative Neoplasms

T. Greiner, M. Lim, C. Hedvat, 2013 .

Translating trial-based molecular monitoring into clinical practice: importance of international standards and practical considerations for community practitioners.

Y. L. Wang, L. Akard, Y. L. Wang, 2011, Clinical lymphoma, myeloma & leukemia.

Laboratory detection of JAK2V617F in human myeloproliferative neoplasms.

Y. L. Wang, Jonathan S. Kui, Rosanny Espinal-Witter, 2013, Methods in molecular biology.

Splenic extramedullary hematopoietic proliferation in Philadelphia chromosome-negative myeloproliferative neoplasms: heterogeneous morphology and cytological composition

R. Hoffman, Y. L. Wang, D. Knowles, 2012, Modern Pathology.

JAK2(V617F) allele burden in polycythemia vera correlates with grade of myelofibrosis, but is not substantially affected by therapy.

A. Jones, R. Silver, Y. L. Wang, 2011, Leukemia research.

Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disorders.

A. Jones, R. Silver, Y. L. Wang, 2007, The Journal of molecular diagnostics : JMD.

Evaluation of JAK2V617F in B and T Cell Neoplasms: Identification of JAK2V617F Mutation of Undetermined Significance (JMUS) in the Bone Marrow of Three Individuals

Y. L. Wang, N. Cross, D. Knowles, 2007, Acta Haematologica.

Consultations in Molecular Diagnostics Amplification Refractory Mutation System, a Highly Sensitive and Simple Polymerase Chain Reaction Assay, for the Detection of JAK2 V617F Mutation in Chronic Myeloproliferative Disorders

A. Jones, R. Silver, Y. L. Wang, 2007 .

Regulation of self-tolerance by CD80/CD86 interactions.

P. Linsley, Y. L. Wang, P. Lu, 1997, Current opinion in immunology.

Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism.

S. Jo, Y. L. Wang, A. Chadburn, 2007, The American journal of pathology.

Molecular monitoring of chronic myeloid leukemia: international standardization of BCR-ABL1 quantitation.

Y. L. Wang, C. Zhen, Y. Lynn Wang, 2013, The Journal of molecular diagnostics : JMD.

Ibrutinib resistance in chronic lymphocytic leukemia.

L. Leape, Y. L. Wang, R. Furman, 2014, The New England journal of medicine.

Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies.

E. Cesarman, R. Blasberg, A. Melnick, 2013, Blood.

Resistance to Bruton tyrosine kinase inhibition in chronic lymphocytic leukaemia and non‐Hodgkin lymphoma

Y. L. Wang, Shazia Nakhoda, A. Vistarop, 2022, British journal of haematology.

JAK2V617F allele burden is reduced by busulfan therapy: a new observation using an old drug

A. Jones, R. Silver, Y. L. Wang, 2013, Haematologica.

Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma

S. Matthew, J. Leonard, E. Cesarman, 2008, British journal of haematology.

Activities of SYK and PLCγ2 Predict Apoptotic Response of CLL Cells to SRC Tyrosine Kinase Inhibitor Dasatinib

J. Leonard, F. Lee, Y. L. Wang, 2010, Clinical Cancer Research.

Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies

Sabah Kadri, Y. L. Wang, J. Leeds, 2017, Clinical Cancer Research.

Characterization of ibrutinib‐sensitive and ‐resistant mantle lymphoma cells

Y. L. Wang, M. Coleman, Shuhua Cheng, 2014, British journal of haematology.

β-Glucuronidase Is an Optimal Normalization Control Gene for Molecular Monitoring of Chronic Myelogenous Leukemia

E. Cesarman, Y. L. Wang, D. Knowles, 2006 .

Molecular monitoring of chronic myelogenous leukemia: identification of the most suitable internal control gene for real-time quantification of BCR-ABL transcripts.

E. Cesarman, D. Jin, Y. L. Wang, 2006, Journal of Molecular Diagnostics.

Decrease in JAK2V617F allele burden is not a prerequisite to clinical response in patients with polycythemia vera

A. Jones, R. Silver, Y. L. Wang, 2012, Haematologica.

JAK2 Mutations are present in all cases of polycythemia vera

R. Silver, Y. L. Wang, N. Cross, 2008, Leukemia.

Dual SYK/JAK inhibition overcomes ibrutinib resistance in chronic lymphocytic leukemia: Cerdulatinib, but not ibrutinib, induces apoptosis of tumor cells protected by the microenvironment

Y. L. Wang, P. Conley, A. Pandey, 2017, Oncotarget.

Detection of BCL2-IGH Using Single-Round PCR Assays

Y. L. Wang, Mario F Gomez, Xuemei Wu, 2005, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Heightened BTK-dependent cell proliferation in unmutated chronic lymphocytic leukemia confers increased sensitivity to ibrutinib

Sonali M. Smith, Y. L. Wang, C. Nabhan, 2015, Oncotarget.

gammaherpesvirus-associated malignancies Targeting the Hsp90-associated viral oncoproteome in

E. Cesarman, R. Blasberg, A. Melnick, 2013 .

Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2.

Michael L. Wang, Y. L. Wang, Xiaoyan Zhou, 2018, Blood advances.

Actions on Cellular Metabolic Activities Promotes Lymphocyte Survival through Its g Peroxisome Proliferator-Activated Receptor

S. Jo, M. Wasik, Y. L. Wang, 2006 .

Molecular and immunohistochemical detection of Kaposi sarcoma herpesvirus/human herpesvirus-8.

Y. L. Wang, A. Chadburn, Janet Wilson, 2013, Methods in molecular biology.

Prognosis in Chronic Lymphocytic Leukemia-Reply.

G. Raca, Y. L. Wang, C. Nabhan, 2015, JAMA oncology.

Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials.

Martin C. Müller, J. Radich, S. Kamel‐Reid, 2008, Blood.